SIGA Technologies | ARS: Annual Report to Security Holders
Apr 26 08:08 ET
SIGA Technologies | DEFA14A: Others
Apr 26 08:08 ET
SIGA Technologies | DEF 14A: Definitive information statements
Apr 26 08:03 ET
SIGA Technologies | 8-K: Siga Technologies, Inc. And Meridian Medical Technologies, Llc Entered into an Amendment to the Promotion Agreement
Apr 1 16:07 ET
SIGA Technologies | 4: Statement of changes in beneficial ownership of securities-Officer Miller Larry R.
Mar 27 16:21 ET
SIGA Technologies | 3: Initial statement of beneficial ownership of securities-Officer Miller Larry R.
Mar 27 16:16 ET
SIGA Technologies | 10-K: Annual report
Mar 12 17:05 ET
SIGA Technologies | 8-K: SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023
Mar 12 16:11 ET
SIGA Technologies | SC 13G: Statement of acquisition of beneficial ownership by individuals
Feb 1 15:57 ET
SIGA Technologies | 4: Statement of changes in beneficial ownership of securities-Officer Nguyen Diem
Jan 30 17:08 ET
SIGA Technologies | 3: Initial statement of beneficial ownership of securities-Officer Nguyen Diem
Jan 30 17:04 ET
SIGA Technologies | 8-K: SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer
Jan 22 00:00 ET
SIGA Technologies | 8-K: Amendment to Amended & Restated Transition Agreement
Jan 2 00:00 ET
SIGA Technologies: Q3 2023 Earnings Report
Nov 7, 2023 17:00 ET
SIGA Technologies | 8-K: SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2023
Nov 7, 2023 16:05 ET
SIGA Technologies | 8-K: SIGA Technologies Names Dr. Jay K. Varma as EVP and Chief Medical Officer
Sep 6, 2023 06:05 ET
SIGA Technologies | 10-Q: Q2 2023 Earnings Report
Aug 8, 2023 16:50 ET
SIGA Technologies | 8-K: SIGA Reports Financial Results for Three and Six Months Ended June 30, 2023
Aug 8, 2023 16:05 ET
SIGA Technologies | 8-K: SIGA Technologies announced Amended and restated transition agreement
Jul 28, 2023 16:08 ET
SIGA Technologies | 8-K: SIGA Technologies Announces U.S. Government Procurement Orders of Approximately $138 Million for Oral and IV TPOXX
Jul 28, 2023 07:08 ET
No Data
No Data